SEQUENT Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sequent

Technical Analysis

Technical Strength: 1.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 35.5. According to RSI analysis, sequent is technically weak. 1.0 SEQUENT RSI Chart
MACD (?) MACD: -1.49 and Signal Line: -0.802. According to MACD analysis, sequent is technically weak. 2.0 SEQUENT MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sequent is in a downtrend. Resistance level is at 72.3. 1.0 SEQUENT Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sequent is in a downtrend. Resistance level is at 72.1. 1.0 SEQUENT Exponential Moving Average Chart
Bollinger Bands (?) %b is -0.142. According to bollinger bands, sequent has hit the lower band which is a negative signal. 1.0 SEQUENT Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 71.7278 and 73.25. Support level is 66.8. 2.5 SEQUENT Fibonacci Retracement Chart
Average True Range (?) ATR: 3.51 NA SEQUENT Average True Range Chart
Average Directional Index (?) ADX is 15.6 which means SEQUENT is in a trading range and there is no trend. NA SEQUENT Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 14, 2019
Open Price 68.7
High Price 68.8
Low Price 66.7
Close Price 67.9
Absolute Change -0.05
Percentage Change -0.0736%
Weekly Change -8.43%
Monthly Change -12.4%
Yearly Change 38.7%
52-week high 89.4
52-week low 48.6
Corporate Actions
ExDate Purpose
August 21, 2019 AGM/DIV-RS 0.20 PER SH
November 20, 2017 INT DIV - RE 0.20 PER SHA
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)1.05
Confidence in Beta6.95%
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 13 November 2019: Deliverable Quantity:6.4e+05 NA SEQUENT Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 13 November 2019: Daily Volatility:0.5158 NA SEQUENT Annualized Daily Volatility (Spot Price) Chart


July 19, 2019 Clarification SEQUENT:The Exchange has sought clarification from Sequent Scientific Limited with respect to announcement dated 05-Jul-2019, regarding the Company has appointed and designated Mr. Tushar Mistry, Chief Financial Officer as Compliance Officer till the time the vacancy of Company Secretary is filled by the Company. On basis of above the Company is required to clarify following: 1. Date of appointment of Mr. Tushar Mistry. The response of the Company is awaited.
April 18, 2018 SeqAcquisitionquent Scientific Limited has informed the Exchange that Alivira Animal Health Limited Ireland which is a subsidiary of Alivira Animal Health Limited a wholly owned subsidiary of the Company has acquired Bremer Pharma GMBH.
See all Announcements

Board Meetings

Date Meeting Date Purpose
November 06, 2019 November 13, 2019 Financial Results To consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019
July 24, 2019 July 31, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play